[1] Li Q,Yuan GY,Tang KC,et al.Prognostic factors for chronic severe hepatitis and construction of a prognostic modal[J].Hepatobiliary Pancreat Dis Int,2008,7(1):40-44. [2] Liaw YF.Hepatitis B virus replication and liver disease progression:the impact of antiviral therapy[J].Antivir Ther,2006,11(6):669-679. [3] Graudal N,Milman N,Kirkegaard E,et al.Bacteremia in cirrhosis of the liver[J].Liver,1986,6(5):297-301. [4] Barnes PF,Arevalo C,Chan LS,et al.A prospective evaluation of bacteremic patients with chronic liver disease[J].Hepatology,1988,8 (5):1099-1103. [5] Liaw YF,Leung N,Guan R,et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2005 update[J].Liver Int,2005,25 (3):472-489. [6] Ben De Panw,Thomas J,Walsh J,et al.Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group[J].Chin Infect Dis,2008,46(12):1813-1821. [7] Netea MG,Van der Meet JW,Kullberg BJ.Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence[J].Clin Microbiol Infect,2006,12(5):404-409. [8] Eugenia P,Charalampos A,Emmanuel R.The role of immunostimulation in the treatment of invasive fungal infection[J].Current Fungal Infection Reports,2008,2(1):28-35. [9] Dilip Ratnam,Kumar Visvanathan.New concepts in the immunopathogenesis of chronic hepatitis B:the importance of the innate immune response[J].Hepatol Int,2008,2 (Supplement 1):12-18. [10] Riordan SM,Skinner N,Kurtovic J,et al.Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chrouic hepatitis B[J].Clin Vaccine Immunol,2006,13 (8):972-974. [11] Visvanathan K,Skinner NA,Thompson A J,et al.Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein[J].Hepatology,2007,45(1):102-110. [12] Cheng J,Imanishi H,Morisaki H,et al.Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NfkappaB pathway in a human monocytic cell line,THP-1[J].J Hepatol,2005,43 (3):465-471. |